View More Recent Stories
-
Acurx Pharmaceuticals (ACXP) Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax Susceptibility to ACX-375 Analogues
-
Acurx Pharmaceuticals (ACXP) Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile Symposium
-
New to the Street Announces Its Five Corporate Interviews, Airing Episode 599 on the Fox Business Network, Tonight Monday, September 9, 2024, at 10:30 PM PT September 9, 2024 09:15 ET
-
Acurx Pharmaceuticals (ACXP) Misses Q2 EPS by 9c
